Two drugs developed by Disc Medicine (IRON) and Sanofi (SNY) are facing delays in their review timelines due to safety and ...
Shares of Disc Medicine jumped after the company said it received a Commissioner's National Priority Voucher from the Food and Drug Administration for its drug bitopertin. The stock climbed 27% to $94 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback